Halyard Health, Inc. (HYH) Lowered to “C+” at TheStreet

TheStreet cut shares of Halyard Health, Inc. (NYSE:HYH) from a b- rating to a c+ rating in a research report sent to investors on Monday morning.

Several other equities research analysts have also recently commented on HYH. BidaskClub cut shares of Halyard Health from a buy rating to a hold rating in a research report on Saturday, July 8th. Zacks Investment Research raised shares of Halyard Health from a hold rating to a buy rating and set a $44.00 price target on the stock in a research report on Wednesday, July 12th. Stephens raised shares of Halyard Health from an equal weight rating to an overweight rating in a research report on Thursday, August 3rd. Deutsche Bank AG boosted their price target on shares of Halyard Health from $35.00 to $42.00 and gave the stock a buy rating in a research report on Thursday, August 3rd. Finally, Stifel Nicolaus reissued a buy rating and set a $45.00 price target on shares of Halyard Health in a research report on Thursday, September 21st. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of Buy and an average price target of $42.25.

Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 EPS for the quarter, topping the consensus estimate of $0.47 by $0.13. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. The firm had revenue of $401.40 million for the quarter, compared to analysts’ expectations of $394.54 million. During the same period in the previous year, the firm posted $0.48 EPS. The company’s revenue for the quarter was up 1.0% on a year-over-year basis.

ILLEGAL ACTIVITY WARNING: “Halyard Health, Inc. (HYH) Lowered to “C+” at TheStreet” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.com-unik.info/2017/11/03/halyard-health-inc-hyh-lowered-to-c-at-thestreet.html.

Several hedge funds have recently modified their holdings of the company. BlackRock Inc. raised its holdings in shares of Halyard Health by 6,362.1% in the 1st quarter. BlackRock Inc. now owns 5,939,352 shares of the medical instruments supplier’s stock valued at $226,229,000 after purchasing an additional 5,847,442 shares during the period. Vanguard Group Inc. raised its holdings in shares of Halyard Health by 4.7% in the 1st quarter. Vanguard Group Inc. now owns 4,350,518 shares of the medical instruments supplier’s stock valued at $165,711,000 after purchasing an additional 196,367 shares during the period. Dimensional Fund Advisors LP raised its holdings in shares of Halyard Health by 19.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,133,049 shares of the medical instruments supplier’s stock valued at $123,067,000 after purchasing an additional 507,893 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Halyard Health by 242.8% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,864,646 shares of the medical instruments supplier’s stock valued at $73,244,000 after purchasing an additional 1,320,735 shares during the period. Finally, State Street Corp raised its holdings in shares of Halyard Health by 7.5% in the 2nd quarter. State Street Corp now owns 1,702,423 shares of the medical instruments supplier’s stock valued at $66,872,000 after purchasing an additional 119,154 shares during the period. 91.03% of the stock is currently owned by institutional investors.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Analyst Recommendations for Halyard Health (NYSE:HYH)

What are top analysts saying about Halyard Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Halyard Health Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit